Literature DB >> 26402103

Longitudinal Neuropsychiatric Predictors of Death in Alzheimer's Disease.

Gianfranco Spalletta1,2, Jeffrey D Long3,4, Robert G Robinson3, Alberto Trequattrini5, Sonia Pizzoli1, Carlo Caltagirone1,6, Maria D Orfei1.   

Abstract

Characteristics associated with life expectancy in Alzheimer's disease (AD) are still far from known. Here we aimed at examining the ability of baseline/longitudinal clinical variables to predict time to death. One-hundred fifty AD outpatients underwent diagnostic, neuropsychiatric, and functional assessment at baseline (when ApoE ɛ4 was also investigated) and at each subsequent annual visit. A random effects joint modeling approach was used to simultaneously model the baseline and longitudinal trajectory of each factor and predict the time to death, adjusting for demographic covariates. An ancillary analysis of ApoE ɛ4 status as a predictor was also conducted. Kaplan-Meier survival curves were constructed to elucidate the relationship between each factor and the estimated probability of death over time. Shorter survival was associated with male gender, higher education, older age, lower cognition, and worse functioning in daily life, but not ApoE ɛ4 status. Longitudinal trajectories increased predictive power over using just baseline levels highlighting apathy, and secondarily aberrant motor behaviors and sleep disorders, as a highly reliable predictor for mortality. Apathy was the strongest neuropsychiatric predictor of time to death, which supports its role in the pathogenesis of the disorder. An increased knowledge of factors modulating survival in AD is a strategic prerequisite to plan therapeutic interventions.

Entities:  

Keywords:  Alzheimer’s disease; apathy; mortality; predictors; prognosis

Mesh:

Substances:

Year:  2015        PMID: 26402103     DOI: 10.3233/JAD-150391

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  19 in total

1.  Sleep Disturbance and the Risk of Cognitive Decline or Clinical Conversion in the ADNI Cohort.

Authors:  Adam P Mecca; Hannah R Michalak; Julia W McDonald; Emily C Kemp; Erika A Pugh; Melinda L Becker; Marcia C Mecca; Christopher H van Dyck
Journal:  Dement Geriatr Cogn Disord       Date:  2018-06-08       Impact factor: 2.959

2.  Apathy is related to reduced activation in cognitive control regions during set-shifting.

Authors:  Nicky G Klaasen; Claire Kos; André Aleman; Esther M Opmeer
Journal:  Hum Brain Mapp       Date:  2017-03-03       Impact factor: 5.038

Review 3.  Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases.

Authors:  Lynn Marie Trotti; Elias G Karroum
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

Review 4.  Apathy: a neurocircuitry model based on frontotemporal dementia.

Authors:  Simon Ducharme; Bruce H Price; Bradford C Dickerson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2017-10-24       Impact factor: 10.154

5.  Association Between Early Psychotic Symptoms and Alzheimer's Disease Prognosis in a Community-Based Cohort.

Authors:  Reena T Gottesman; Anton Kociolek; Kayri Fernandez; Stephanie Cosentino; D P Devanand; Yaakov Stern; Yian Gu
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

6.  Geographic variation in Alzheimer's disease mortality.

Authors:  Michael Topping; Jinho Kim; Jason Fletcher
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240

7.  Recommendations for the Use of ICT in Elderly Populations with Affective Disorders.

Authors:  Auriane Gros; David Bensamoun; Valeria Manera; Roxane Fabre; Anne-Marie Zacconi-Cauvin; Susanne Thummler; Michel Benoit; Philippe Robert; Renaud David
Journal:  Front Aging Neurosci       Date:  2016-11-08       Impact factor: 5.750

8.  Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments.

Authors:  Krista L Lanctôt; Roberta W Scherer; Abby Li; Danielle Vieira; Hamadou Coulibaly; Paul B Rosenberg; Nathan Herrmann; Alan J Lerner; Prasad R Padala; Olga Brawman-Mintzer; Chris H van Dyck; Anton P Porsteinsson; Suzanne Craft; Allan Levey; William J Burke; Jacobo E Mintzer
Journal:  Am J Geriatr Psychiatry       Date:  2020-05-27       Impact factor: 4.105

9.  Disease-related determinants are associated with mortality in dementia due to Alzheimer's disease.

Authors:  Hanneke F M Rhodius-Meester; Hilkka Liedes; Ted Koene; Afina W Lemstra; Charlotte E Teunissen; Frederik Barkhof; Philip Scheltens; Mark van Gils; Jyrki Lötjönen; Wiesje M van der Flier
Journal:  Alzheimers Res Ther       Date:  2018-02-20       Impact factor: 6.982

Review 10.  Kampo Medicines for Frailty in Locomotor Disease.

Authors:  Hajime Nakae; Yuko Hiroshima; Miwa Hebiguchi
Journal:  Front Nutr       Date:  2018-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.